Privately-held NeoRx Corp enter exclusive agreement Genentech Inc development injectable diagnostic image blood clots. It Genentech responsible marketing NeoRx receive royalty base sales. The product proprietary NeoRx method attach radioisotope technetium-99m Genentech's blood clot dissolve drug tissue plasminogen activator Activase. Reuter 